In the setting of cancer, this variability has been linked with many predictors, including the expression of PD‐L1/PD‐L2 in tumor tissue,243, 244 the presence of tumor‐infiltrating lymphocytes in the tumor microenvironment245 and their metabolic state,246 and the tumor mutational burden.247. Here, CD274 is linked to cancer.